Mon panier

Recombinant Monoclonal Anti-PSMA Antibody, Rabbit (9A2)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Availability
Qté
HGS-S317-20ul
$195.00
In Stock - Delivery in 2-3 business days
HGS-S317-100ul
$570.00
In Stock - Delivery in 2-3 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Background

    Recombinant Monoclonal Anti-PSMA Antibody, Rabbit (9A2) is a PSMA primary antibody for IHC application. PSMA is transmembrane glycoprotein belonging to the M28 peptidase family. The protein acts as a glutamate carboxypeptidase on different alternative substrates, including the nutrient folate and the neuropeptide N-acetyl-l-aspartyl-l-glutamate and is expressed in a number of tissues such as prostate, central and peripheral nervous system and kidney.

  • Product Specifications

    Host Species
    Rabbit
    Isotype
    Rabbit IgG, Rabbit Kappa
    Clone
    9A2
    Application
    IHC-P
    Dilution Ratio
    1: 500 - 1: 2000
    Form
    Liquid
    Clonality
    Monoclonal
    Reactivity
    Human
    Synonyms
    GCPII
    Concentration
    0.9~1.1 mg/ml
    Specificity
    React with PSMA protein on the membrane of target cell/tissue
    Purification Tech
    Protein A
    Preservation
    PBS, BSA, Glycerol
  • Experiment Protocol

    LEICA Experiment Protocol

  • Storage

    Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
    Avoid freeze / thaw cycle. Upon delivery aliquot. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Sample Staining Data

     PSMA SAMPLE STAINING DATA
  •  PSMA SAMPLE STAINING DATA
  •  PSMA SAMPLE STAINING DATA

    Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HGS-S317 at 1/1000 dilution.
    Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Prostate-Specific Membrane Antigen

  • Catégorie:

  • Nombre de médicaments répertoriés:

    6 Détails

  • Nombre de médicaments cliniques:

    159 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs